logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
U

Umang Swami

Yale University
H指数:27
被引数:3,167

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluation of Time to Metastasis After Prostatectomy as a Prognostic Factor in Patients With Metachronous mHSPC: A Secondary Analysis of the SWOG-1216 Phase 3 Trial

前列腺切除术后转移时间作为异时性mHSPC患者预后因素的评估：SWOG-1216 III期试验的二次分析

Prostate
IF2.5
2026-10-070
OAAI
Nicolas Sayegh; Yeonjung Jo; Umang Swami; Varun Nandakumar; Georges Gebrael; Zeynep Irem Ozay; Haoran Li; Krishnam Goel; Benjamin L. Maughan; Melissa Plets; Maha H. A. Hussain; Tanya B. Dorff; Primo N. Lara Jr.; Amir Goldkorn; Seth P. Lerner; Neeraj Agarwal
How enfortumab vedotin plus pembrolizumab affects the quality of life of people with advanced urothelial cancer compared with platinum-based chemotherapy: a plain language summary of patient-reported outcomes from the EV-302 study

恩福妥单抗联合帕博利珠单抗与铂类化疗相比对晚期尿路上皮癌患者生活质量的影响：EV-302研究患者报告结局的通俗语言摘要

Future Oncology
IF2.6
2026-04-010
PRE
Gupta, Shilpa; Loriot, Yohann; Van der Heijden, Michiel S.; Bedke, Jens; Valderrama, Begona P.; Kikuchi, Eiji; Flechon, Aude; Petrylak, Daniel; De Santis, Maria; Galsky, Matthew D.; Lee, Jae Lyun; Swami, Umang; Sridhar, Srikala S.; De Giorgi, Ugo; Wright, Phoebe; Shih, Vanessa; Lu, Yi-Tsung; Guan, Xuesong; Dillon, Ryan; Shetty, Aditya; Homet Moreno, Blanca; Beaumont, Jennifer L.; Purnajo, Intan; McManus, Shauna; Powles, Thomas
Molecular Landscape of Prostate Cancers with Clival Metastases

伴有蝶骨转移的前列腺癌的分子景观

The Oncologist
IF0
2026-03-040
OA
Pornlada Likasitwatanakul; Steven M Blinka; Jabra G Zarka; Georges Gebrael; Emily Weg; Ossian Longoria; Joseph A Moore; Adam Sharp; Johann de Bono; Cora N Sternberg; Neeraj Agarwal; Umang Swami; Jacob J Orme; Michael T Schweizer; Lindsey Sloan; Justin H Hwang; Emmanuel S Antonarakis
Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trials

种族与接受阿帕鲁他胺治疗患者生存期的关联：两项III期试验的合并分析

Cancer
IF5.1
2026-01-010
PRE
Gebrael, Georges; Agarwal, Neeraj; Morgans, Alicia K.; Vince, Randy; Swami, Umang; Jia, Angela Y.; Zaorsky, Nicholas; Chehade, Chadi Hage; Ozay, Zeynep Irem; Malone, Shawn; Morgan, Scott C.; Wallis, Christopher J. D.; Kishan, Amar U.; Barata, Pedro C.; Chowdhury, Simon; Garcia, Jorge A.; Sheng, Iris; Brown, Jason R.; Small, Eric J.; Sun, Yilun; Shore, Neal D.; Saad, Fred; Spratt, Daniel E.; Roy, Soumyajit
Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer

早期对转移性激素敏感型前列腺癌的 prostate-specific antigen (PSA) 阳性反应预测

Nature Communications
IF15.7
2025-12-170
OAAI
Soumyajit Roy; Yilun Sun; Maha Hussain; Kim N. Chi; Karim Fizazi; Ian D. Davis; Susan Halabi; Neeraj Agarwal; Simon Chowdhury; Bertrand Tombal; Scott C. Morgan; Shawn Malone; Pedro C. Barata; Michael Ong; Christopher J. D. Wallis; Alejandro Berlin; Umang Swami; Amar U. Kishan; Angela Y. Jia; Nicholas G. Zaorsky; Jorge A. Garcia; Prateek Mendiratta; Jason R. Brown; Vinod V. Subhash; Martin R. Stockler; Hayley Thomas; Rana R. McKay; Eric J. Small; Neal D. Shore; Fred Saad; Christopher J. Sweeney; Daniel E. Spratt
IUC24428-85 Real-world effectiveness of ipilimumab plus nivolumab in second-line in patients with metastatic clear cell renal cell carcinoma (mccRCC) based on prior receipt of PD-1/L1 inhibitors

IUC24428-85 基于既往接受PD-1/L1抑制剂治疗的患者，伊匹木单抗联合纳武利尤单抗在二线治疗转移性透明细胞肾细胞癌（mccRCC）中的真实世界有效性

The Oncologist
IF0
2025-08-290
OA
Z I Ozay; Y Jo; G Gebrael; M Ostrowski; E Murdock; S Jamie-Casas; M Zugman; N Agarwal; S Pal; U Swami
Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial

不可切除的增生性黑色素瘤的Anti-PD-1治疗: SWOG S1512 2期试验

Nature Medicine
IF50
2025-08-140
PRE
Kari L. Kendra; Shay L. Bellasea; Zeynep Eroglu; Siwen Hu-Lieskovan; Katie M. Campbell; William E. Carson; David A. Wada; Jose A. Plaza; Jeffrey A. Sosman; Gino K. In; Alexandra Ikeguchi; John Hyngstrom; Andrew S. Brohl; I. Khushalani Nikhil; Joseph Markowitz; George Negrea; Samer Kasbari; Gary C. Doolittle; Umang Swami; Toni Roberts; Boban N. Mathew; Egmidio Medina; Ignacio Baselga-Carretero; Cynthia R. Gonzalez; Ivan Perez Garcilazo; Agustin Vega-Crespo; Jia Ming Chen; Nataly Naser Al-Deen; Sapna P. Patel; Elad Sharon; James Moon; Michael C. Wu; Antoni Ribas
Exploratory subgroup analyses of EV-302: a phase III global study to evaluate enfortumab vedotin in combination with pembrolizumab versus chemotherapy in previously untreated locally advanced or metastatic urothelial carcinoma

EV-302研究的探索性亚组分析：一项评估恩诺单抗（enfortumab vedotin）联合帕博利珠单抗（pembrolizumab）与化疗对比治疗既往未治疗的局部晚期或转移性尿路上皮癌的III期全球研究

ESMO Open
IF8.3
2025-08-110
OAAI
M.S. van der Heijden; T. Powles; S. Gupta; Y. Loriot; M.D. Galsky; B.P. Valderrama; S.S. Sridhar; E.Y. Yu; G. Iyer; E. Kikuchi; D. Castellano; J. Hoffman-Censits; A. Drakaki; N. Mar; J.P. Maroto Rey; C. Vulsteke; W. Arafat; I. Duran; N.A. Dawson; U. Swami; S. Gorla; B.H. Moreno; X. Yu; Y.-T. Lu; J. Bedke
Enfortumab vedotin plus pembrolizumab in untreated locally advanced or metastatic urothelial carcinoma: 2.5-year median follow-up of the phase III EV-302/KEYNOTE-A39 trial☆

恩诺单抗维多汀联合帕博利珠单抗治疗未经治疗的局部晚期或转移性尿路上皮癌：III期EV-302/KEYNOTE-A39试验的中位2.5年随访结果☆

Annals of Oncology
IF65.4
2025-06-010
PREAI
T.B. Powles; M.S. Van der Heijden; Y. Loriot; J. Bedke; B.P. Valderrama; G. Iyer; E. Kikuchi; J. Hoffman-Censits; C. Vulsteke; A. Drakaki; S. Rausch; W. Arafat; S.H. Park; U. Swami; J.-R. Li; I. Duran; S. Gorla; B. Homet Moreno; X. Yu; Y.-T. Lu; S. Gupta
Enfortumab vedotin plus pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial cancer (EV-302): patient-reported outcomes from an open-label, randomised, controlled, phase 3 study

恩诺单抗维多汀联合帕博利珠单抗对比化疗在先前未经治疗的局部晚期或转移性尿路上皮癌患者中的疗效（EV-302）：一项开放标签、随机对照、III期研究的患者报告结局

lancet oncology
IF0
2025-05-280
PRE
Shilpa Gupta; Yohann Loriot; Michiel S Van der Heijden; Jens Bedke; Begoña P Valderrama; Eiji Kikuchi; Aude Fléchon; Daniel Petrylak; Maria De Santis; Matthew D Galsky; Jae Lyun Lee; Umang Swami; Srikala S Sridhar; Ugo De Giorgi; Phoebe Wright; Vanessa Shih; Yi-Tsung Lu; Xuesong Guan; Ryan Dillon; Aditya Shetty; Blanca Homet Moreno; Jennifer L Beaumont; Intan Purnajo; Shauna McManus; Thomas Powles
Response to: Comment on Nivolumab adjuvant to chemo-radiation in localized muscle-invasive urothelial cancer: primary analysis of a multicenter, single-arm, phase II, investigator-initiated trial (NEXT)

回复：关于Nivolumab辅助化疗放疗在局部肌肉浸润性尿路上皮癌中的应用：一项多中心、单臂、II期、研究者发起试验（NEXT）的主要分析

JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2025-05-260
OA
Fortuna, Gliceida M. Galarza; Swami, Umang; Gupta, Sumati
T-cell Engagers in Prostate Cancer

T细胞结合剂在前列腺癌中的应用

EUROPEAN UROLOGY
IF25.2
2025-05-011
PRE
Chehade, Chadi Hage; Ozay, Zeynep Irem; Ostrowski, Micah; Mercinelli, Chiara; Gebrael, Georges; Sayegh, Nicolas; Swami, Umang; Azad, Arun A.; Antonarakis, Emmanuel S.
Nivolumab adjuvant to chemo-radiation in localized muscle-invasive urothelial cancer: primary analysis of a multicenter, single-arm, phase II, investigator-initiated trial (NEXT)

Nivolumab作为化疗放疗的辅助治疗在局部肌肉浸润性尿路上皮癌中的应用：一项多中心、单臂、II期、研究者发起试验（NEXT）的初步分析

JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2025-03-182
OA
Galarza Fortuna, Gliceida M.; Grass, Daniel; Maughan, Benjamin L.; Jain, Rohit K.; Dechet, Christopher; Beck, Julia; Schuetz, Ekke; Sanchez, Alejandro; O'Neil, Brock; Poch, Michael; Li, Roger; Lloyd, Shane; Tward, Jonathan; Phunrab, Tenzin; Hawks, Josiah Lyn; Swami, Umang; Boucher, Kenneth M.; Agarwal, Neeraj
Genomic biomarkers of survival in patients with metastatic hormone-sensitive prostate cancer undergoing intensified androgen deprivation therapy

接受强化雄激素剥夺治疗的转移性激素敏感性前列腺癌患者生存的基因组生物标志物

PROSTATE CANCER AND PROSTATIC DISEASES
IF5.8
2025-01-310
PRE
Gebrael, Georges; Sayegh, Nicolas; Chehade, Chadi Hage; Jo, Yeonjung; Narang, Arshit; Chigarira, Beverly; Tripathi, Nishita; Srivastava, Ayana; Tandar, Clara; Williams, Jessica F.; Garg, Diya; Ji, Richard; Maughan, Benjamin L.; Swami, Umang; Agarwal, Neeraj

研究方向

暂未获取到该数据
N
Neeraj Agarwal
H 指数:6论文数:45被引数:634
B
Benjamin L. Maughan
H 指数:29论文数:393被引数:3,288
G
Georges Gebrael
H 指数:10论文数:146被引数:467
N
Nicolas Sayegh
H 指数:17论文数:199被引数:1,875
N
Nishita Tripathi
H 指数:13论文数:126被引数:560
V
Vinay Mathew Thomas
H 指数:10论文数:142被引数:541
C
Chadi Hage Chehade
H 指数:7论文数:101被引数:165
G
Gliceida Galarza Fortuna
H 指数:8论文数:92被引数:289
Y
Yeonjung Jo
H 指数:9论文数:117被引数:603
R
Roberto Nussenzveig
H 指数:28论文数:203被引数:3,034